PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Share News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,189.00
Bid: 1,186.00
Ask: 1,188.00
Change: -6.00 (-0.50%)
Spread: 2.00 (0.169%)
Open: 1,200.00
High: 1,200.00
Low: 1,171.00
Prev. Close: 1,195.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fevertree backs FY guidance after 'good start' to year

Thu, 25th May 2023 10:06

(Sharecast News) - Posh tonic maker Fevertree Drinks backed its full-year guidance on Thursday following a "good start" to the year.

In an update ahead of its annual meeting, the company said trading has been in line with the expectations set out in the FY22 results.

In the UK, the firm recorded its highest-ever value share in the on-trade segment during a first quarter trading period, around 6% higher than its share in the first quarter of 2020. Fevertree said it expects its off-trade sales to build momentum as the year progress, and that it is trading in line with expectations in the UK.

The US business had a strong star to the year in both on and off-trade, with good value and volume growth across all categories, and particularly strong growth in flavoured sparkling and club soda drinks.

Fevertree said that in Europe, it continues to gain value share of the premium mixer category at retail, with particularly encouraging growth in Italy and France.

In Rest of World, the group continues to make good sales and operational progress across regions.

"We are confident that the brand will continue to deliver strong revenue growth as we start our key summer trading period and therefore reiterate our top-line guidance range as set out in March at £390m to £405m," it said.

"Whilst inflationary cost pressures remain elevated, the group continues to be focused on delivering initiatives to mitigate these costs and expects to drive margin improvements as we progress through the year, which means we're on-track to deliver EBITDA in-line with our guidance range of £36m to £42m for 2023."

More News
22 Jul 2022 08:59

RBC Capital downgrades Fever-Tree, slashes price target

(Sharecast News) - RBC Capital Markets downgraded tonic maker Fever-Tree on Friday to 'underperform' from 'sector perform' and slashed the price target to 700p from 1,600p.

Read more
22 Jul 2022 08:12

LONDON BRIEFING: JD Sports backs guidance but UK retail sales weak

(Alliance News) - JD Sports backed annual guidance on a day that brought mixed reports on the UK's wider retail sector.

Read more
21 Jul 2022 09:52

LONDON BROKER RATINGS: Citi likes Haleon, resumes GSK at 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
20 Jul 2022 09:41

LONDON BROKER RATINGS: Goldman likes Haleon but says sell Schroders

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Jul 2022 09:50

LONDON BROKER RATINGS: Fevertree chopped; Berenberg likes Deliveroo

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Jul 2022 08:22

Barclays downgrades Fever-Tree after profit warning

(Sharecast News) - Barclays downgraded tonic maker Fever-Tree on Tuesday to 'equalweight' from 'ovewrweight' following its third profit warning in six months.

Read more
18 Jul 2022 09:52

Jefferies, Deutsche Bank downgrade Fever-Tree

(Sharecast News) - Tonic maker Fever-Tree was downgraded by both Jefferies and Deutsche Bank on Monday following a profit warning last week.

Read more
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
18 Jul 2022 08:56

LONDON MARKET OPEN: Insurers fall; Euromoney surges as backs takeover

(Alliance News) - Stocks in Europe kicked off the new week on the front foot as expectations of a chunky 100 basis point rate hike from the US Federal Reserve ebbed, with markets now largely pricing in a 75 basis point increase.

Read more
18 Jul 2022 08:10

LONDON BRIEFING: Direct Line adds to warnings from UK motor insurers

(Alliance News) - Direct Line Insurance on Monday cautioned on "heightened volatility across the UK motor insurance market", adding another warning from London-listed insurers.

Read more
15 Jul 2022 22:14

DIRECTOR DEALINGS: Fevertree CEO buys shares worth GBP1 million

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

Read more
15 Jul 2022 17:13

LONDON MARKET CLOSE: Stocks higher as US rate hikes fears calm

(Alliance News) - Stocks in London ended the week in the green after positive retail sales data from the US, easing fears over future US interest rate hikes.

Read more
15 Jul 2022 14:08

Director dealings: Fevertree CEO spends £1m after disappointing update

(Sharecast News) - Fevertree Drinks was at the top of the list of director buys on Friday, after its co-founder and chief executive splashed on over £1m of shares.

Read more
15 Jul 2022 12:26

LONDON MARKET MIDDAY: Aston Martin jumps on backing from Saudi fund

(Alliance News) - Stocks in London were broadly higher at midday on Friday, amid easing fears over future US interest rate hikes, while the AIM market was weighed down by a lowered earnings guidance from highly rated Fevertree Drinks.

Read more
15 Jul 2022 11:21

AIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.